Finding a cure for hepatitis B: are we close? WHO overview on the topic

During a traditional ELISpot assay, low HBV Specific T cell frequencies have... [Read more]

This protocol describes the approach used to stain formalin-fixed paraffin-embedded liver biopsy slides w... [Read more]

• cccDNA quantification from total DNA preparation by qPCR with cccDNA-selective primers is cha... [Read more]

• Sothern blot is considered the “gold standard” for cccDNA detection because it can separate t... [Read more]

During a traditional FluroSpot assay, low HBV Specific T cell frequencies have hindered effective ex vivo... [Read more]

Fluorescently conjugated antigen-bait systems have been extensively used to identify antigen-specific B c... [Read more]

The frequency of HBV-specific CD8+ T cells can be very low, depending on the specificity. Therefore, they... [Read more]

• Although a plethora of knowledge on the molecular life cycle of Hepatitis B Virus has been ga... [Read more]

• This assay characterizes the products of HBV RNase H activity on a DNA:RNA heteroduplex.
• Products are resolved by denaturing PAGE to assess specificity of cleavage and effects of inhibitory compounds on the enzyme

• This assay detects the activity of HBV RNaseH using fluorescence resonance energy transfer[Read more]